Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299494
Status:
COMPLETED
Last Update Posted:
2018-03-08
First Post:
2006-03-02
Brief Title:
Study Evaluating Inotuzumab Ozogamicin CMC-544 Administered In Combination With Rituximab In Subjects With Non-Hodgkins Lymphoma NHL
Sponsor:
Organization:
Pfizer